drugset / Trial / NCT04274803
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will address the value of adding intralipid infusion in reducing pregnancy complications related to antiphospholipid syndrome
Timeline
- Start
- 2020-04-01
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Intralipid | Other / unclassified | 4 ml | Intravenous |
| Comparator | Enoxaparin sodium | Other / unclassified | 4000 iu | — |
| Comparator | Ezacard | Unknown | 75 mg | — |